Optomed Oyj

HEL:OPTOMED.HE

3.16 (EUR) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

20232022202120202019201820172016
Revenue 15.114.6614.8513.01114.97714.4636.8996.609
Cost of Revenue 4.8575.4485.1024.2135.2864.9543.1182.99
Gross Profit 10.2439.2129.7488.7989.6919.5093.7813.619
Gross Profit Ratio 0.6780.6280.6560.6760.6470.6570.5480.548
Reseach & Development Expenses 0.230.3610.4120.2760.3561.0720.2270.532
General & Administrative Expenses 2.5090.7650.8660.7140.5041.650.220.251
Selling & Marketing Expenses 0.6350.7840.6740.4220.4890.5090.6470.648
SG&A 3.1441.5491.541.1360.9932.1590.8670.899
Other Expenses 0.04911.97312.16810.13110.55210.1745.5154.82
Operating Expenses 14.21713.88314.1211.54311.90110.1746.6096.251
Operating Income -3.974-4.671-4.372-2.745-2.21-0.665-2.827-2.611
Operating Income Ratio -0.263-0.319-0.294-0.211-0.148-0.046-0.41-0.395
Total Other Income Expenses Net -0.545-0.880.045-0.502-0.742-0.783-0.062-0.13
Income Before Tax -4.519-5.551-4.327-3.247-2.952-1.221-2.89-2.762
Income Before Tax Ratio -0.299-0.379-0.291-0.25-0.197-0.084-0.419-0.418
Income Tax Expense -0.079-0.079-0.078-0.07-0.0770.048-0.003-0.003
Net Income -4.441-5.472-4.249-3.177-2.875-1.268-2.887-2.758
Net Income Ratio -0.294-0.373-0.286-0.244-0.192-0.088-0.418-0.417
EPS -0.27-0.37-0.32-0.24-0.32-0.096-0.22-0.21
EPS Diluted -0.27-0.37-0.32-0.24-0.32-0.096-0.22-0.21
EBITDA -1.302-1.251-0.966-0.743-0.3171.372-1.65-1.905
EBITDA Ratio -0.086-0.085-0.065-0.057-0.0210.095-0.239-0.288